AcquisitionOther
Immunome Inc. acquired Morphimmune
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Immunome Inc. -> Morphimmune · $125 Million
Siegall, Ph.D., current Morphimmune President & CEO and former co-founder & CEO of Seagen, Inc., to serve as Chairman and CEO of combined company · A concurrent $125 million private placement investment with leading institutional investors will support
Open source record (SEC) ↗